Your shopping cart is currently empty

Revusiran (ALN-TTRSC) is a first-generation short interfering RNA (siRNA) that specifically targets transthyretin (TTR) mRNA and is utilized in TTR-mediated amyloidosis research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | Inquiry | Inquiry |
| Description | Revusiran (ALN-TTRSC) is a first-generation short interfering RNA (siRNA) that specifically targets transthyretin (TTR) mRNA and is utilized in TTR-mediated amyloidosis research. |
| In vitro | Revusiran is a first-generation, chemically synthesized, double-stranded short interfering RNA (siRNA) with its sense strand's 3′-end covalently bonded to a triantennary GalNAc (N-acetylgalactosamine) ligand. This design enables Revusiran to specifically target transthyretin (TTR) mRNA, facilitating its delivery to hepatocytes. The uptake occurs through the asialoglycoprotein receptors, optimizing the compound's efficiency in silencing the TTR gene[1]. |
| In vivo | In monkeys, single doses up to 100 mg/kg do not affect cardiovascular or respiratory functions, and no neurological effects were observed in repeat-dose studies up to 300 mg/kg. Similarly, revusiran demonstrates good tolerability in mice (weekly doses) and both rats and monkeys (five daily doses followed by weekly doses) in toxicity studies[1]. |
| Synonyms | ALN-TTRSC |
| Cas No. | 1438322-82-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.